Rajesh Malik - 01 Feb 2022 Form 4 Insider Report for G1 Therapeutics, Inc. (GTHX)

Role: Chief Medical Officer
Signature: /s/ James Stillman Hanson, attorney-in-fact
Issuer symbol: GTHX
Transactions as of: 01 Feb 2022
Transactions value $: $3,000
Form type: 4
Filing time: 02 Feb 2022, 16:20:40 UTC
Previous filing: 05 Jan 2022
Next filing: 06 Jun 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	GTHX	Common Stock	Options Exercise	$3,000	+10,000	+15.66%	$0.3	73,855	01 Feb 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	GTHX	Stock Option (Right to Buy)	Options Exercise	$0	-10,000	-15.38%	$0	55,000	01 Feb 2022	Common Stock	10,000	$0.3	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents (i) 53,605 shares of common stock; (ii) 8,250 RSUs from award granted on January 4, 2021; and (iii) 12,000 RSUs from award granted on January 3, 2022.
F2	All shares underlying this option have vested.